| Date |
Event |
Presentation |
Speakers |
|
July 21, 2013
|
Molecular Biology of Aging
|
http://hermes.mbl.edu/education/courses/special_topics/bag.html
|
David A Sinclair, M. S. Meselson, George Church
|
|
May 8, 2013
|
Chromatin and epigenetics
|
Kevin Struhl, Harvard Medical School, USA
|
Kevin Struhl
|
|
|
|
Robert Kingston, Massachusetts General Hospital, USA
|
Robert Kingston
|
|
|
|
Craig Peterson, University of Massachusetts Medical School, USA
|
Craig L Peterson
|
|
May 1, 2013
|
New Model Systems for Linking Evolution and Ecology
|
Session 4 - Emerging models - animals Chair: Bettina Harr, MPI for Evolutionary Biology, Germany
|
Arkhat Abzhanov
|
|
April 6, 2013
|
AACR Annual Meetings
|
EPIGENETIC TARGETS FOR CANCER
|
Anjana Rao, James E. Bradner
|
|
|
|
Developmental Origins of Cancer Chairperson: Richard J. Gilbertson, St. Jude Children's Research Hospital, Memphis, TN
|
Stuart H. Orkin
|
|
|
|
Blood-Based Molecular Analysis of Cancer
|
Daniel A Haber
|
|
|
|
Intrinsic and Microenvironment-Dependent Adaptive Responses that Regulate Drug Resistance Chairperson: Joan S. Brugge, Harvard Medical School, Boston, MA
|
Joan S Brugge
|
|
|
|
The Interface Between Development and Cancer Using Model Organisms Chairperson: Michael M. Shen, Columbia University, New York, NY
|
Leonard I. Zon
|
|
|
|
Emerging Single Cell Technologies in Cancer Research Chairperson: Garry P. Nolan, Stanford University School of Medicine, Stanford, CA
|
Claude Lechene
|
|
|
|
Mutations in Epigenetic Regulators in Cancer Chairperson: Scott A. Armstrong, Memorial Sloan-Kettering Cancer Center, New York, NY
|
Scott A. Armstrong
|
|
|
|
Mitotic Checkpoints Driving Cancer Therapeutic Strategies Chairperson: Peter K. Jackson, Genentech, Inc., South San Francisco, CA
|
Timothy J Mitchison
|
|
|
|
Translational Control and Stress Response Pathways in Cancer Chairperson: Davide Ruggero, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA
|
Karen Cichowski
|
|
|
|
Developmental and Molecular Origins of Brain Tumors Co-Chairpersons: Suzanne J. Baker, St. Jude Children's Research Hospital, Memphis, TN, and Cameron W. Brennan, Memorial Sloan-Kettering Cancer Center, New York, NY
|
Cameron W Brennan
|
|
|
|
Synthetic Lethality and Genetic Approaches to Cancer Chairperson: Stephen J. Elledge, Harvard Medical School, Boston, MA
|
Stephen J Elledge
|
|
|
|
Structural Aberrations in a Thousand Tumors Chairperson: Raju Kucherlapati, Harvard Medical School, Boston, MA
|
Raju Kucherlapati
|
|
|
|
The Stanley J. Korsmeyer Memorial Symposium: Targeting Cell Death Pathways for Cancer Therapy Chairperson: Anthony G. Letai, Dana-Farber Cancer Institute, Boston, MA
|
Anthony G. Letai
|
|
|
|
The Origins and Clinical Implications of Precancerous Lesions Chairperson: Cory Abate-Shen, Columbia University Irving Comprehensive Cancer Center, New York, NY
|
Kornelia Polyak
|
|
|
|
Noncoding RNAs and Cancer Chairperson: Phillip A. Sharp, David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA
|
Jeannie T. Lee
|
|
|
|
New Cancer Vaccines Chairperson: Glenn Dranoff, Dana-Farber Cancer Institute, Boston, MA
|
Glenn Dranoff
|
|
|
|
The Origins and Neoplastic Progression of Barrett's Esophagus Co-Chairpersons: Timothy C. Wang, Columbia University Medical Center, New York, NY, and Brian J. Reid, Fred Hutchinson Cancer Research Center, Seattle, WA
|
Frank McKeon
|
|
|
|
Molecular Basis and Therapeutic Targeting of Bone Metastasis Co-Chairpersons: Yibin Kang, Princeton University, Princeton, NJ, and Matthew R. Smith, Massachusetts General Hospital Cancer Center, Boston, MA
|
Matthew Smith
|
|
|
|
Molecular and Cellular Determinants of Brain Metastasis Co-Chairpersons: William C. Hahn, Dana-Farber Cancer Institute, Boston, MA, and Joan Massagué, Memorial Sloan-Kettering Cancer Center, New York, NY
|
Rakesh K Jain, William C Hahn
|
|
|
|
Avatar: Individualized Human Cancer Models in Mice
|
Kwok-Kin Wong
|
|
|
|
Next-Generation Therapeutic Modeling in Mice
|
Pier Paolo
|
|
|
|
The Utility of Cancer Cell Line Screens for Modeling Drug Sensitivities Moderator: Jeffrey Settleman, Genentech, Inc., South San Francisco, CA
|
Levi A Garraway
|
|
|
|
Clinical Trials Based on Mutations versus Histology
|
William R Sellers, Lewis C Cantley
|
|
|
|
Human Papillomavirus: Beyond Cervical Cancer Chairperson: Maura L. Gillison, The Ohio State University Comprehensive Cancer Center, Columbus, OH
|
Peter M Howley
|
|
|
|
From Chemistry to the Clinic: Pathways for Drug Discovery and Development, Part 1: Targeting Mechanisms of Therapeutic Resistance Chairperson: Matt V. Lorenzi, Janssen Research & Development, Spring House, PA
|
Kwok-Kin Wong
|
|
|
|
Credentialing Response Biomarkers for Signal Transduction Inhibitors Chairperson: Neal Rosen, Memorial Sloan-Kettering Cancer Center, New York, NY
|
Anthony G. Letai
|
|
|
|
Therapeutic Nanotechnology Chairperson: Gregory Lanza, Washington University, St. Louis, MO
|
Omid C Farokhzad
|
|
|
|
Rational Combination Therapies in Cancer Chairperson: Gordon B. Mills, The University of Texas MD Anderson Cancer Center, Houston, TX
|
Scott A. Armstrong
|
|
|
|
The Next Frontier in Targeted Therapy for Melanoma Chairperson to be announced
|
Lynda Chin
|
|
|
|
New Paradigms in Molecular Pharmacology Chairperson: Angela N. Koehler, Broad Institute of MIT and Harvard, Cambridge, MA
|
James E. Bradner
|
|
|
|
Metabolism and Signaling in Cancer Chairperson: Eyal Gottlieb, The Beatson Institute for Cancer Research, Glasgow, United Kingdom
|
Nika N. Danial
|
|
|
|
Immune Modulation in the Tumor Microenviroment Chairperson: James P. Allison, Memorial Sloan-Kettering Cancer Center, New York, NY
|
Raghu Kalluri
|
|
|
|
Cancer Imaging in Mice and Men Andrew L. Kung, Dana-Farber Cancer Institute, Boston, MA
|
Andrew Kung
|
|
|
|
2-Oxoglutarate-Dependent Dioxygenases as Targets of Cancer-Causing Mutations and Cancer Therapeutics William G. Kaelin, Jr., Dana-Farber Cancer Institute, Boston, MA
|
William G Kaelin
|
|
|
|
Tumor-Secreted Factors Chairperson: David C. Lyden, Weill Cornell Medical College of Cornell University, New York, NY
|
Xandra O Breakefield
|
|
|
|
Autocrine Activation of MET and Strategies to Overcome Adaptation for the Targeted Therapy of Acute Myeloid Leukemia A. Thomas Look, Dana-Farber Cancer Institute, Boston, MA
|
Thomas A. Look
|
|
|
|
Stapled Peptides as Next-Generation Therapeutics Gregory L. Verdine, Harvard University, Cambridge, MA
|
Gregory L Verdine
|
|
|
|
Prognostic and Predictive Biomarkers of Triple-Negative Breast Cancer Andrea L. Richardson, Brigham and Women's Hospital, Boston, MA
|
Andrea L Richardson
|
|
|
|
Cancer Omics Beyond the Genome
|
Sunney Xie
|
|
|
|
16th Annual Grant Writing Workshop Building Presence and Leadership through Empowered Communication Co-Chairpersons: Martine J. Piccart, Institut Jules Bordet, Brussels, Belgium, and Victoria M. Richon. Epizyme, Inc., Wellesley Hills, MA
|
Kornelia Polyak
|
|
|
|
Patient-Derived Xenograft Models of Cancer: Where Are We Going? Chairperson: Matthew J. Ellis, Washington University Siteman Cancer Center, St. Louis, MO
|
Tan Ince
|
|
|
|
WICR Career Mentoring Session
|
Joan S Brugge
|
|
May 8, 2011
|
Omics Meets Cell Biology (E1)
|
Large-Scale Analyses of Signaling Networks
|
Norbert Perrimon
|
|
January 10, 2011
|
Histone Code: Fact or Fiction? (A6)
|
Investigating the Mechanism of Inheritance of Polycomb Group proteins through DNA Replication in vitro. | Matterhorn Ballroom
|
Nicole J. Francis
|
|
|
|
Histone Modifications in Heterochromatin Assembly and Propagation | Matterhorn Ballroom
|
Danesh Moazed
|
|
|
|
Three-Dimensional Organization of Chromosomes | Matterhorn Ballroom
|
Job Dekker
|
|
|
|
Histone Demethylation | Matterhorn Ballroom
|
Yang Shi
|
|
January 10, 2011
|
Second Annual Targeting Genes, Engineering Vectors, Designing Constructs, and Optimizing Clones
|
Applications with an Enhanced Unnatural Amino Acid Incorporation Platform
|
Travis Young
|
|
November 15, 2010
|
RNA Control of Cell Dynamics European Molecular Biology Organization
|
RNA control of cell dynamics
|
Joel Richter
|
|
September 15, 2010
|
8th International Conference on Bone Morphogenetic Proteins
|
Title pending
|
Herb Lin
|
|
September 5, 2010
|
EMBO|EMBL Symposium: Structure and Function of Neural Circuits
|
Keynote Lecture
|
Jeff Lichtman
|
|
|
|
Neurobiology of Motivation and Emotion | By Catherine Dulac
|
Catherine Dulac
|
|
|
|
Cerebellum and Motor Systems | By Florian Engert
|
Florian Engert
|
|
|
|
Information Processing in Sensory Systems | By Mark Daly
|
Mark Daly
|
|
|
|
Information Processing in Sensory Systems | By Rachel Wilson
|
Rachel Wilson
|
|
|
|
Information Processing in Sensory Systems | By Markus Meister
|
Markus Meister
|
|
July 11, 2010
|
3rd International Congress On Stem Cells And Tissue Formation
|
Biomaterials for Cell Transplantation and Drug Delivery | Amy Brock
|
Amy Brock
|
|
|
|
Programming Cells In Vivo Using Polymers
|
David J. Mooney
|
|
June 17, 2010
|
Institute of Structural and Molecular Biology 4th Symposium
|
Drugging Oncogenic Transcription Factors
|
Gregory Verdine
|
|
May 12, 2010
|
Stem Cells, Tissue Homeostasis and Cancer
|
Keynote Lecture
|
Stuart Orkin
|
|
April 11, 2010
|
Synapses: Formation, Function and Misfunction (Z3)
|
Keynote Address (Joint) | Ballroom 2-3
|
Michael E. Greenberg
|
|
|
|
Short Talk: Deep Tissue Supraresolution Imaging of Neurons Using Stimulated-Emission Depletion 2-Photon Laser Scanning Microscopy | Ballroom 3
|
Jun Ding
|
|
October 1, 2009
|
6TH ANNUAL MEETING OF THE INTERNATIONAL SOCIETY OF GASTROINTESTINAL ONCOLOGY (ISGIO)
|
Case Presentation 1: Stage II
|
David Ryan
|
|
June 22, 2009
|
Symposium: Light Microscopy meets Structural Biology
|
Combining structural and FRET studies to investigate the activational switch of Focal Adhesion Kinase
|
Daniel Lietha
|
|
December 4, 2008
|
BIT Life Sciences 2nd Annual World Congress of Gene-2008 (WCG 2008)
|
TBD
|
Yu-Li Wang
|
|
|
|
Co-Chair :Track 2-8
|
Zhen Y. Jiang
|
|
|
|
Analyzing Insulin Signaling Networks and Metabolic Functions Using Quantitative Proteomics Approach :Track 2-8
|
Zhen Y. Jiang
|
|
|
|
Oral Delivery of Glucan Encapsulated siRNA to Macrophages Targeting Map4K4 Attenuates Systemic Inflammation :Track 2-8
|
Myriam Aouadi
|
|
|
|
Developmental Origin of Adipose Tissue: Novel Role of Bone Morphogenetic Proteins in Adipogenesis and Energy Metabolism :Track 2-8
|
Yu-Hua Tseng
|
|
|
|
Title: TBD : Track 4-4
|
Jing X. Kang
|
|
August 3, 2008
|
Joint Metastasis Research Society-AACR Conference on Metastasis
|
Regulation of Tumor Growth and Metastasis by the Antizyme Pathway
|
Bruce R. Zetter
|
|
|
|
Dissecting Steps of Metastasis by Intravital Microscopy
|
Rakesh K Jain
|
|
May 30, 2008
|
ASCO Annual'08 Meeting
|
breast cancer-- Adjuvant Chemotherapy of Breast Cancer: Do We Still Need Anthracyclines?
|
Eric P. Winer
|
|
|
|
breast cancer-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14A)
|
Judy E Garber
|
|
|
|
breast cancer-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14B)
|
Judy E Garber
|
|
|
|
cancer genetics-- Molecular Pathways of Cancer Predisposition in Children, Adolescents, and Young Adults
|
Lisa Diller
|
|
|
|
cancer genetics-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14A)
|
Judy E Garber
|
|
|
|
cancer genetics-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14B)
|
Judy E Garber
|
|
|
|
cancer prevention/epidemiology-- Molecular Pathways of Cancer Predisposition in Children, Adolescents, and Young Adults
|
Lisa Diller
|
|
|
|
cancer prevention/epidemiology-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14A)
|
Judy E Garber
|
|
|
|
cancer prevention/epidemiology-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14B)
|
Judy E Garber
|
|
|
|
central nervous system tumors-- Managing the Medical Complications of Patients with Brain Tumors (CPO10A)
|
Patrick Y. Wen
|
|
|
|
central nervous system tumors-- Managing the Medical Complications of Patients with Brain Tumors (CPO10B)
|
Patrick Y. Wen
|
|
|
|
clinical trials-- Early Data: Presenting and Publishing Preliminary Results
|
Donna S. Neuberg
|
|
|
|
ethics-- Early Data: Presenting and Publishing Preliminary Results
|
Donna S. Neuberg
|
|
|
|
gastrointestinal (noncolorectal) cancer-- Gastrointestinal Stromal Tumor (GIST) Comes of Age: Current Management Using Molecular Pathology, Surgery, and Targeted Therapy
|
George Daniel Demetri
|
|
|
|
geriatric oncology--Adjuvant Chemotherapy of Breast Cancer: Do We Still Need Anthracyclines?
|
Eric P. Winer
|
|
|
|
lung cancer-- Targeted and Novel Agents in Small Cell Lung Cancer
|
Bruce E. Johnson
|
|
|
|
melanoma/skin cancers-- Melanoma in Children, Adolescents, and Young Adults
|
David E Fisher
|
|
|
|
patient and survivor care-- Managing the Medical Complications of Patients with Brain Tumors (CPO10A)
|
Patrick Y. Wen
|
|
|
|
patient and survivor care-- New Models for Survivorship Care Programs (M15)
|
Lawrence N. Shulman
|
|
|
|
patient and survivor care-- Treatment Approaches and Functional Outcomes in Pediatric Sarcomas
|
Mark Gebhardt
|
|
|
|
patient and survivor care-- Managing the Medical Complications of Patients with Brain Tumors (CPO10B)
|
Patrick Y. Wen
|
|
|
|
pediatric cancer-- Molecular Pathways of Cancer Predisposition in Children, Adolescents, and Young Adults
|
Lisa Diller
|
|
|
|
pediatric cancer-- Challenges and Optimizing Outcomes in Adolescents and Young Adults with Cancer
|
Karen H. Albritton
|
|
|
|
pediatric cancer-- Treatment Approaches and Functional Outcomes in Pediatric Sarcomas
|
Mark Gebhardt
|
|
|
|
pediatric cancer-- Melanoma in Children, Adolescents, and Young Adults
|
David E Fisher
|
|
|
|
sarcoma/bone and soft tissue cancers-- Predicting and Targeting Drug Resistance to Tyrosine Kinase Inhibitors
|
Jeffrey Adam Engelman
|
|
|
|
sarcoma/bone and soft tissue cancers-- Treatment Approaches and Functional Outcomes in Pediatric Sarcomas
|
Mark Gebhardt
|
|
|
|
tumor biology-- Predicting and Targeting Drug Resistance to Tyrosine Kinase Inhibitors
|
Jeffrey Adam Engelman
|
|
|
|
meet the professor sessions-- New Models for Survivorship Care Programs (M15)
|
Lawrence N. Shulman
|
|
|
|
clinical problems in oncology-- Managing the Medical Complications of Patients with Brain Tumors (CPO10A)
|
Patrick Y. Wen
|
|
|
|
clinical problems in oncology-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14A)
|
Judy E Garber
|
|
|
|
clinical problems in oncology-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14B)
|
Judy E Garber
|
|
|
|
clinical problems in oncology-- Managing the Medical Complications of Patients with Brain Tumors (CPO10B)
|
Patrick Y. Wen
|
|
January 12, 2008
|
Molecular Basis for Biological Membrane Organization (A2)
|
Membrane Morphogenesis
|
Tom A Rapoport
|
|
January 6, 2008
|
Frontiers of Structural Biology
|
Macromolecular Dynamics: Experiment and Theory
|
Gerhard Wagner
|
|
|
|
Membrane Protein Structure
|
James Jeiwen Chou
|
|
|
|
Pushing the Limits of Structural Biology II: Advances in Methodologies for Structure Determination (Joint)
|
Gerhard Wagner
|
|
December 1, 2007
|
47TH American Socieity of Cell Biology
|
Design Principles for Connecting the Genome to the World
|
I Philips, C. Ajo-Franklin
|
|
|
|
Minisymposium 1A:Cell Biology Working Group: Challenges in Cell Biology—The Nature of Cytoplasm
|
Timothy J Mitchison
|
|
|
|
Interphase and Mitotic CDKs Follow Kinetically Distinct Paths to Activation in Human Cells.
|
C. Zhang
|
|
|
|
*Single-Molecule Analysis Reveals the Distribution of Potential vs. Active DNA Replication Origins in Human Cells
|
R. Lebofsky
|
|
|
|
Cell Matrix Interactions (Room 140A)
|
Yu-Li Wang
|
|
|
|
Advances in Bone Cell Molecular Biology: Epigenetic Control
|
Jane Lian, Gary S Stein
|
|
|
|
CLASPs Clutching Microtubule Networks (Room 209 B/C)
|
David Van Vactor
|
|
|
|
At the Limits: Optical Methods for Single Molecules, Cells, and Organisms
|
Jennifer Waters, Samara Rech-Peterson
|
|
|
|
High Performance Image Analysis and Photomanipulative Techniques for
|
Jeffrey Nickerson
|
|
|
|
Building the Cell (Room 140B)
|
L Mahadevan
|
|
|
|
Systems Biology of Receptor Tyrosine Kinase Networks (Room 206)
|
Peter K. Sorger
|
|
|
|
Public Service Award Presentation
|
Matthew Michael
|
|
|
|
Primary Role for Centrosome Proteins in Cilia Formation and Cilia-associated Disorders
|
B Delaval, L Covassin Barberis, N Lawson, Stephen J Doxsey
|
|
|
|
Cell-Type Variation in Responses to Anti-mitotic Drugs.
|
C Loy, J Orth, C Shamu, M Tsui, V Yanamadala, Timothy J Mitchison
|
|
|
|
Fluorescence Correlation Spectroscopy Workshop
|
Daniel Needham
|
|
|
|
Actin Disassembly by Whole-Filament Destabilization.v
|
H Kueh, W M Brieher, Timothy J Mitchison
|
|
|
|
How Does Thrombospondin Induce CNS Synaptogenesis?
|
J. T. Lawler
|
|
|
|
Identifying Matrix- and Growth Factor-induced Transcriptional Dichotomies by Stochastic Sampling.
|
K A Janes, Joan Brugge
|
|
|
|
High-Tech Cell Biology
|
Kendall Knight
|
|
|
|
DNA Damage Signaling Events Revealed by 4Pi Microscopy.
|
Kendall Knight, Brian T Bennett
|
|
|
|
Novel Microscopy Methodology to Examine DNA Damage Signaling and Repair.
|
Brian T Bennett
|
|
|
|
Heterochromatin Formation in Fission Yeast.
|
M Huarte, Yang Shi
|
|
|
|
Anti-fi brotic Property of CTGF siRNA in the Liver via Targeted Delivery to Hepatic Stellate Cells.
|
David Roger Brigstock, C Lawrencia
|
|
|
|
Mallory Body Formation in the Livers of Drug-primed Mice Is Regulated by an Epigenetic Mechanism
|
Jian Li
|
|
|
|
Myosin-activated Random Stress Fluctuations in the Actin Cytoskeleton
|
David Weitz
|
|
|
|
Cytoplasmic Dynein Is a Better Navigator than Kinesin on Tau-decorated Microtubules.
|
J. L. Ross
|
|
|
|
Determining the Molecular Architectures of Cellular Machines by Satisfaction of Spatial Restraints: The Nuclear Pore Complex.
|
Adrian Salic
|
|
|
|
Posters Displayed:Monday
|
Joan Brugge
|
|
|
|
Amaxa GmbH:
|
Alan D Andrea
|
|
|
|
Post-Cytokinetic DNA Segregation by ATPases That Form DNA-Conducting Channels
|
Tom A Rapoport, N L Sullivan, K Marquis
|
|
|
|
Maintenance of Polarity and Cell Shape in Vibrio cholerae
|
Matthew K Waldor
|
|
|
|
Biochemical Characterization of Type III-secreted Bacterial Acetyltransferases
|
J Orth
|
How We Rank